Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Hair shaft miniaturization leads to hair follicle stem cell loss, suggesting Piezo1 as a potential treatment target.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Matriptase is crucial for skin, hair, and immune cell health, and its imbalance can lead to cancer.

Copper-quercetin complexes could be effective in treating cancer, infections, and promoting bone healing.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Targeting senescent cells may offer new treatments for PCOS.

More research is needed to understand how testosterone is maintained in adult males.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

A woman's mature cystic teratoma caused her virilization by producing testosterone.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.